Mortality of HIV-infected patients starting antiretroviral therapy in sub-Saharan Africa: comparison with HIV-unrelated mortality.Reportar como inadecuado

Mortality of HIV-infected patients starting antiretroviral therapy in sub-Saharan Africa: comparison with HIV-unrelated mortality. - Descarga este documento en PDF. Documentación en PDF para descargar gratis. Disponible también para leer online.

* Corresponding author 1 ISPM - Institute of Social and Preventive Medicine Bern 2 Infectious Diseases Epidemiology Unit, School of Public Health and Family Medicine 3 Lighthouse Clinic 4 Centre de Prise en Charge de Recherches et de Formation 5 Information, Evidence and Research Cluster 6 The Desmond Tutu HIV Centre 7 ISPED - Institut de Santé Publique, d-Epidémiologie et de Développement 8 Newlands clinic 9 Department of Social Medicine

Abstract : BACKGROUND: Mortality in HIV-infected patients who have access to highly active antiretroviral therapy ART has declined in sub-Saharan Africa, but it is unclear how mortality compares to the non-HIV-infected population. We compared mortality rates observed in HIV-1-infected patients starting ART with non-HIV-related background mortality in four countries in sub-Saharan Africa. METHODS AND FINDINGS: Patients enrolled in antiretroviral treatment programmes in Côte d-Ivoire, Malawi, South Africa, and Zimbabwe were included. We calculated excess mortality rates and standardised mortality ratios SMRs with 95% confidence intervals CIs. Expected numbers of deaths were obtained using estimates of age-, sex-, and country-specific, HIV-unrelated, mortality rates from the Global Burden of Disease project. Among 13,249 eligible patients 1,177 deaths were recorded during 14,695 person-years of follow-up. The median age was 34 y, 8,831 67% patients were female, and 10,811 of 12,720 patients 85% with information on clinical stage had advanced disease when starting ART. The excess mortality rate was 17.5 95% CI 14.5-21.1 per 100 person-years SMR in patients who started ART with a CD4 cell count of less than 25 cells-microl and World Health Organization WHO stage III-IV, compared to 1.00 0.55-1.81 per 100 person-years in patients who started with 200 cells-microl or above with WHO stage I-II. The corresponding SMRs were 47.1 39.1-56.6 and 3.44 1.91-6.17. Among patients who started ART with 200 cells-microl or above in WHO stage I-II and survived the first year of ART, the excess mortality rate was 0.27 0.08-0.94 per 100 person-years and the SMR was 1.14 0.47-2.77. CONCLUSIONS: Mortality of HIV-infected patients treated with combination ART in sub-Saharan Africa continues to be higher than in the general population, but for some patients excess mortality is moderate and reaches that of the general population in the second year of ART. Much of the excess mortality might be prevented by timely initiation of ART.

Autor: Martin Brinkhof - Andrew Boulle - Ralf Weigel - Eugène Messou - Colin Mathers - Catherine Orrell - François Dabis - Margaret Pa



Documentos relacionados